These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 23010947)

  • 21. Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances anti-tumor responses of peripheral blood mononuclear cells from human lung cancer patients.
    Ren T; Wen ZK; Liu ZM; Qian C; Liang YJ; Jin ML; Cai YY; Xu L
    Cancer Invest; 2008 Jun; 26(5):448-55. PubMed ID: 18568766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CpG oligodeoxynucleotides induce the expression of the antimicrobial peptide cathelicidin in glial cells.
    Brandenburg LO; Jansen S; Albrecht LJ; Merres J; Gerber J; Pufe T; Tauber SC
    J Neuroimmunol; 2013 Feb; 255(1-2):18-31. PubMed ID: 23141747
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CpG oligodeoxynucleotide preconditioning improves cardiac function after myocardial infarction via modulation of energy metabolism and angiogenesis.
    Zhou DC; Su YH; Jiang FQ; Xia JB; Wu HY; Chang ZS; Peng WT; Song GH; Park KS; Kim SK; Cai DQ; Zheng L; Qi XF
    J Cell Physiol; 2018 May; 233(5):4245-4257. PubMed ID: 29057537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymphoma immunotherapy with CpG oligodeoxynucleotides requires TLR9 either in the host or in the tumor itself.
    Li J; Song W; Czerwinski DK; Varghese B; Uematsu S; Akira S; Krieg AM; Levy R
    J Immunol; 2007 Aug; 179(4):2493-500. PubMed ID: 17675511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential cytokine production and bystander activation of autoreactive B cells in response to CpG-A and CpG-B oligonucleotides.
    Avalos AM; Latz E; Mousseau B; Christensen SR; Shlomchik MJ; Lund F; Marshak-Rothstein A
    J Immunol; 2009 Nov; 183(10):6262-8. PubMed ID: 19864612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bacterial DNA induces myocardial inflammation and reduces cardiomyocyte contractility: role of toll-like receptor 9.
    Knuefermann P; Schwederski M; Velten M; Krings P; Ehrentraut H; Rüdiger M; Boehm O; Fink K; Dreiner U; Grohé C; Hoeft A; Baumgarten G; Koch A; Zacharowski K; Meyer R
    Cardiovasc Res; 2008 Apr; 78(1):26-35. PubMed ID: 18194990
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toll-like receptor 9 regulates tumor necrosis factor-alpha expression by different mechanisms. Implications for osteoclastogenesis.
    Amcheslavsky A; Zou W; Bar-Shavit Z
    J Biol Chem; 2004 Dec; 279(52):54039-45. PubMed ID: 15485822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased intracellular TLR9 confers hyporesponsiveness of RAW264.7 cells to subsequent CpG ODN challenge.
    Wei L; Hong Z; Jiang Z; Guofu D; Hongwei C; Liangxi W; Yongling L; Bin L; Ping L
    Int Immunopharmacol; 2006 Jun; 6(6):935-46. PubMed ID: 16644479
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic targeting of TLR9 inhibits cell growth and induces apoptosis in neuroblastoma.
    Brignole C; Marimpietri D; Di Paolo D; Perri P; Morandi F; Pastorino F; Zorzoli A; Pagnan G; Loi M; Caffa I; Erminio G; Haupt R; Gambini C; Pistoia V; Ponzoni M
    Cancer Res; 2010 Dec; 70(23):9816-26. PubMed ID: 20935225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CpG preconditioning regulates miRNA expression that modulates genomic reprogramming associated with neuroprotection against ischemic injury.
    Vartanian KB; Mitchell HD; Stevens SL; Conrad VK; McDermott JE; Stenzel-Poore MP
    J Cereb Blood Flow Metab; 2015 Feb; 35(2):257-66. PubMed ID: 25388675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA.
    Ivanov S; Dragoi AM; Wang X; Dallacosta C; Louten J; Musco G; Sitia G; Yap GS; Wan Y; Biron CA; Bianchi ME; Wang H; Chu WM
    Blood; 2007 Sep; 110(6):1970-81. PubMed ID: 17548579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antimalarial artesunate protects sepsis model mice against heat-killed Escherichia coli challenge by decreasing TLR4, TLR9 mRNA expressions and transcription factor NF-kappa B activation.
    Li B; Zhang R; Li J; Zhang L; Ding G; Luo P; He S; Dong Y; Jiang W; Lu Y; Cao H; Zheng J; Zhou H
    Int Immunopharmacol; 2008 Mar; 8(3):379-89. PubMed ID: 18279792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The roles of Toll-like receptor 9, MyD88, and DNA-dependent protein kinase catalytic subunit in the effects of two distinct CpG DNAs on dendritic cell subsets.
    Hemmi H; Kaisho T; Takeda K; Akira S
    J Immunol; 2003 Mar; 170(6):3059-64. PubMed ID: 12626561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Toll-like receptor 9 signaling by CpG-B oligodeoxynucleotides induces an apoptotic pathway in human chronic lymphocytic leukemia B cells.
    Liang X; Moseman EA; Farrar MA; Bachanova V; Weisdorf DJ; Blazar BR; Chen W
    Blood; 2010 Jun; 115(24):5041-52. PubMed ID: 20339095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TLR9 ligand CpG-ODN applied to the injured mouse cornea elicits retinal inflammation.
    Chinnery HR; McLenachan S; Binz N; Sun Y; Forrester JV; Degli-Esposti MA; Pearlman E; McMenamin PG
    Am J Pathol; 2012 Jan; 180(1):209-20. PubMed ID: 22085974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TLR9-mediated siRNA delivery for targeting of normal and malignant human hematopoietic cells in vivo.
    Zhang Q; Hossain DM; Nechaev S; Kozlowska A; Zhang W; Liu Y; Kowolik CM; Swiderski P; Rossi JJ; Forman S; Pal S; Bhatia R; Raubitschek A; Yu H; Kortylewski M
    Blood; 2013 Feb; 121(8):1304-15. PubMed ID: 23287859
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Toll like receptor 9 antagonism modulates spinal cord neuronal function and survival: Direct versus astrocyte-mediated mechanisms.
    Acioglu C; Mirabelli E; Baykal AT; Ni L; Ratnayake A; Heary RF; Elkabes S
    Brain Behav Immun; 2016 Aug; 56():310-24. PubMed ID: 27044334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Colony-stimulating factor-1 suppresses responses to CpG DNA and expression of toll-like receptor 9 but enhances responses to lipopolysaccharide in murine macrophages.
    Sweet MJ; Campbell CC; Sester DP; Xu D; McDonald RC; Stacey KJ; Hume DA; Liew FY
    J Immunol; 2002 Jan; 168(1):392-9. PubMed ID: 11751985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increases in tumor necrosis factor-alpha following transient global cerebral ischemia do not contribute to neuron death in mouse hippocampus.
    Murakami Y; Saito K; Hara A; Zhu Y; Sudo K; Niwa M; Fujii H; Wada H; Ishiguro H; Mori H; Seishima M
    J Neurochem; 2005 Jun; 93(6):1616-22. PubMed ID: 15935078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of toll-like receptor-9 induces matrix metalloproteinase-9 expression through Akt and tumor necrosis factor-alpha signaling.
    Lim EJ; Lee SH; Lee JG; Chin BR; Bae YS; Kim JR; Lee CH; Baek SH
    FEBS Lett; 2006 Aug; 580(18):4533-8. PubMed ID: 16870179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.